Key points are not available for this paper at this time.
We undertook a prospective study to quantitate Burkholderia pseudomallei in blood, urine, respiratory secretions, and pus corrected obtained from 414 patients with melioidosis. The median was count 1.1, 1.5 x 10(4), 1.1 x 10(5), and 1.1 x 10(7) CFU/mL in these sample types, respectively. This provides important insights into the likely feasibility of future studies such as expression microarray analysis using clinical material.
Wuthiekanun et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: